![Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial - The Lancet Oncology Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d8fd767e-dcbf-4d5e-9a26-1e783dd15f33/gr1.gif)
Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial - The Lancet Oncology
Running Department - [ALL SLOTS TAKEN] RD X PUMA DEVIATE NITRO SHOE TRIALS 👟 Wanna give the new PUMA Deviate Nitro Shoe a try? Join us for a shoe trial from 21
![CLASSIC TRIAL MAGAZINE ISSUE 40 SPRING 2021 : https://bit.ly/Classic-Trial-Magazine-40 – Trial Magazine UK CLASSIC TRIAL MAGAZINE ISSUE 40 SPRING 2021 : https://bit.ly/Classic-Trial-Magazine-40 – Trial Magazine UK](https://www.trialmaguk.com/wp-content/uploads/2022/02/10.jpg)